A phase I/II trial investigating the safety and efficacy of autologous TAC T cells targeting HER2 in relapsed or refractory solid tumors.
| Autor: | Schlechter, Benjamin L., Olson, Daniel, Saibil, Samuel, George, Mridula Annette, Gruber, Kelly, Bouvier, Riemke, Pieke, Brooke, Geisburger, Jill, Moss, Kara M., Ternus, Nathan, Adib, Deyaa R, Dumbrava, Ecaterina Elena |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, pTPS816-TPS816, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|